Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Early diagnosis and a combination of treatments can effectively manage hair loss and improve quality of life.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

More research is needed before using brown fat to treat polycystic ovary syndrome.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Diet may influence acne development.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.

Statins can reduce androgen levels and improve symptoms in women with PCOS.

Statins significantly reduce testosterone and improve skin symptoms in women with PCOS.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

Androgen levels do not determine the type of PCOS symptoms in young females.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

HAIR-AN syndrome is common in young women and can be effectively managed with a comprehensive treatment plan.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.